NCT06420167View on ClinicalTrials.gov

DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

PHASE2RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions

Renal AL Amyloidosis

Interventions

DRUG

Dapagliflozin

10mg orally once daily

Trial Locations (1)

48201

RECRUITING

Karmanos Cancer Institute, Detroit

All Listed Sponsors

lead

Barbara Ann Karmanos Cancer Institute

OTHER